US approves first marijuana-based drug
The US Food and Drug Administration (FDA) has approved the first marijuana-based medicine in the country which will be used in the treatment of epilepsy. The FDA approved the drug Epidiolex developed by UK-based firm GW Pharmaceuticals. The drug will be used to treat seizures associated with Lennox-Gastaut syndrome (LGS) and Dravet syndrome in patients aged two years or above. 